date:Oct 31, 2018
ublic webinar on Dec. 3, during which well discuss the science behind genome editing in animals, the promising uses of this technology in animals and the potential risks, and information about CVMs flexible risk-based approach to the regulation of intentional genomic alterations to animals. CVM will also address some of the common misconceptions about the FDAs regulation of these products. At this webinar, the FDAs Center for Biologics Evaluation and Research will also provide information about